Orion Biotech Opportunities (Orion Biotech Opportunities) Change In Receivables : $0.00 Mil (TTM As of Dec. 2022)

View and export this data going back to 2021. Start your Free Trial

What is Orion Biotech Opportunities Change In Receivables?

Orion Biotech Opportunities's change in receivables for the quarter that ended in Dec. 2022 was $0.00 Mil. It means Orion Biotech Opportunities's Accounts Receivable stayed the same from Sep. 2022 to Dec. 2022 .

Orion Biotech Opportunities's change in receivables for the fiscal year that ended in Dec. 2022 was $0.00 Mil. It means Orion Biotech Opportunities's Accounts Receivable stayed the same from Dec. 2021 to Dec. 2022 .

Orion Biotech Opportunities's Accounts Receivable for the quarter that ended in Dec. 2022 was $0.00 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. Orion Biotech Opportunities's liquidation value for the three months ended in Dec. 2022 was $-8.07 Mil.

Orion Biotech Opportunities Change In Receivables Historical Data

The historical data trend for Orion Biotech Opportunities's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Orion Biotech Opportunities Change In Receivables Chart

Orion Biotech Opportunities Annual Data

Trend

Dec21

Dec22

Change In Receivables

Orion Biotech Opportunities Quarterly Data
	Feb21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22
Change In Receivables	Get a 7-Day Free Trial			-	-	-	-	-

Orion Biotech Opportunities Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Dec. 2022 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00 Mil.

Orion Biotech Opportunities (OTCPK:ORIAU) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Orion Biotech Opportunities's Days Sales Outstanding for the quarter that ended in Dec. 2022 is calculated as:

	Days Sales Outstanding
=	Accounts Receivable	/	Revenue	*	Days in Period
=	0	/	0	*	91
=

2. In Ben Graham's calculation of liquidation value, Orion Biotech Opportunities's accounts receivable are only considered to be worth 75% of book value:

Orion Biotech Opportunities's liquidation value for the quarter that ended in Dec. 2022 is calculated as:

	Liquidation Value
=	Cash, Cash Equivalents, Marketable Securities	-	Total Liabilities	+	(0.75 * Accounts Receivable)	+	(0.5 * Total Inventories)
=	0.266	-	8.332	+	0.75 * 0	+	0.5 * 0
=	-8.07

Orion Biotech Opportunities Change In Receivables Related Terms

Thank you for viewing the detailed overview of Orion Biotech Opportunities's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.